Previous Close | 10.17 |
Open | 10.04 |
Bid | 10.33 x 800 |
Ask | 10.42 x 900 |
Day's Range | 10.02 - 10.60 |
52 Week Range | 5.48 - 16.15 |
Volume | 23,311 |
Avg. Volume | 217,209 |
Market Cap | 339M |
Beta (3Y Monthly) | 2.12 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.51 |
Earnings Date | Nov 5, 2019 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 9.00 |
Q3 2019 American Renal Associates Holdings Inc Earnings Call
Joe Carlucci has been the CEO of American Renal Associates Holdings, Inc. (NYSE:ARA) since 2005. This analysis aims...
American Renal Associates Holdings, Inc. (ARA), a leading kidney care and dialysis provider focused on partnering with local nephrologists, today announced that it will release its third quarter 2019 financial results after the market close on Tuesday, November 5, 2019, to be followed by a conference call on Wednesday, November 6, 2019 at 9:00 a.m. (Eastern Time). The conference call can be accessed live over the phone by dialing (877) 407-8029, or for international callers (201) 689-8029. A replay will be available one hour after the call and can be accessed by dialing (877) 660-6853, or for international callers (201) 612-7415.
NEW YORK, Oct. 05, 2019 -- Bragar Eagel & Squire is investigating certain officers and directors of Acadia Healthcare Company, Inc. (NASDAQ: ACHC), American Renal.
NEW YORK , Sept. 19, 2019 /PRNewswire/ -- Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City , is investigating potential claims involving the directors and officers ...
Preliminary Q2 2019 American Renal Associates Holdings Inc Earnings Call
Bragar Eagel & Squire is investigating certain officers and directors of Lannett Company, Inc. (LCI), Molson Coors Brewing Company (TAP), AxoGen, Inc. (AXGN), and American Renal Associates Holdings, Inc. (ARA) on behalf of long-term stockholders. Bragar Eagel and Squire is investigating certain officers and directors of Lannett Company, Inc. following a class action complaint that was filed against Lannett on November 16, 2016.
SAN DIEGO, Aug. 06, 2019 -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in American Renal Associates Holdings, Inc. (NYSE: ARA).
NEW YORK, July 31, 2019 -- Levi & Korsinsky announces it has commenced an investigation of American Renal Associates Holdings, Inc.- (NYSE: ARA) concerning possible.
Bragar Eagel & Squire, P.C. is investigating potential claims against certain officers and directors of American Renal Associates, Inc., Molson Coors Brewing Company, and Orion Group Holdings. On March 8, 2019, American Renal Associates announced it would delay the filing if its earnings report for the fiscal year ended December 31, 2018 as it continues to examine reserve computations and other accounting practices that may have an impact on the company’s accounts receivable and revenue for fiscal year 2018, as well as previously reported fiscal years from 2014 to 2017.
Q1 2019 American Renal Associates Holdings Inc Earnings Call
NEW YORK, NY / ACCESSWIRE / May 28, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq.
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming May 28, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of American Renal Associates Holdings, Inc. (“American Renal” or the “Company”) (NYSE: ARA) investors who purchased securities between August 10, 2016 and March 27, 2019, inclusive (the “Class Period”). If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at 310-201-9150, Toll-Free at 888-773-9224, or by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. On March 8, 2019, American Renal disclosed that in October 2018 the U.S. Securities and Exchange Commission (“SEC”) had requested documents and information regarding revenue recognition, collections, and other related matters.
NEW YORK, NY / ACCESSWIRE / May 28, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have ...
NEW YORK, NY / ACCESSWIRE / May 28, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review ...
ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 28, 2019 to file lead plaintiff applications in a securities class action lawsuit against American Renal Associates Holdings, Inc. (ARA). Investor losses must relate to purchases of the Company’s securities between August 10, 2016 and March 27, 2019. American Renal investors should visit us at https://www.claimsfiler.com/cases/view-american-renal-associates-holdings-inc-securities-litigation-1 or call toll-free (844) 367-9658.
NEW YORK, NY / ACCESSWIRE / May 26, 2019 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have ...